Location
United States, North America
Check Size
$100K - $5M
Investment Stage
Seed
Series A
Series B
Focus Areas
BioTech
Pharmaceuticals
About Investor
Patrick Heron is the Managing Partner at Frazier Healthcare Partners, focusing on investments in Pharmaceuticals and BioTech sectors at seed, Series A, and Series B stages with investment ranges between $100K and $5.0M. Heron has been a General Partner with Frazier since September 1999 and became a General Partner with the onset of FH V in 2005, bringing extensive experience in healthcare investments and company formations from the San Francisco Bay Area.
Previous investments
Alpha9 Theranostics
180M |2024
75M |2022
MBX Biosciences
120M |2022
35M |2020
Passage Bio
110M |2019
120M |2019
Similar Investors
AL
Abdul Ly
United States, North America
$1M - $4M
Seed
,Series A
,PS
Paul Straub
United States, North America
$100K - $2M
Pre Seed
,Seed
,SA
Shaun Abrahamson
United States, North America
$250K - $1M
Pre Seed
,Seed
,RF
Riley Florsheim
United States, North America
$100K - $5M
Pre Seed
,Seed
,SB
Steve Brownlie
United States, North America
$250K - $1.4M
Pre Seed
,Seed
,DG
Danielle Graham
Canada, North America
$100K - $300K
Pre Seed
,Seed
,Is this You?
Is this you? Have any edits?
Fill out our update request form and we'll update ASAP